Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2000, p. 676-681, Vol. 44, No. 3
Department of Pharmacy, Kings College London,
London SW3 6LX,1 Biological Sciences
Department, University of Warwick, Coventry CV4
7AL,2 and Department of Clinical
Microbiology, University College Hospital, London WC1E
6DB,3 United Kingdom
Received 9 July 1999/Returned for modification 25 August
1999/Accepted 22 December 1999
Three fluorescent nucleic acid binding dyes
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Flow Cytometric Monitoring of Antibiotic-Induced
Injury in Escherichia coli Using Cell-Impermeant
Fluorescent Probes
propidium iodide,
TO-PRO-1, and SYTOX green
were evaluated, and their abilities to
distinguish between bacterial cells with and without an intact cytoplasmic membrane were compared. Each dye was readily able to
discriminate between healthy and permeabilized cells of
Escherichia coli, although SYTOX green showed a greater
enhancement in fluorescence intensity on staining-compromised, as
opposed to healthy, cells in log-phase growth, than either PI or
TO-PRO-1. Flow cytometric analysis of E. coli stained with
these dyes after exposing them to several antimicrobial agents showed
that all three dyes were able to detect antimicrobial action. Notably,
however, the intensity of the cell-associated fluorescence was related
to the mechanism of action of the antimicrobial agent. Large changes in
fluorescence intensity were observed for all the dyes subsequent to
-lactam antibiotic action, but smaller changes (or no change) were
seen subsequent to exposure to antimicrobials acting directly or
indirectly on nucleic acid synthesis. Furthermore, cell-associated
fluorescence did not relate to loss of viability as determined by plate
counts. Despite offering much insight into antimicrobial mechanisms of action, these fundamental problems become relevant to the development of rapid antimicrobial susceptibility tests if colony formation is used
as the standard.
*
Corresponding author. Mailing address: Department of
Clinical Microbiology, University College Hospital, Grafton Way, London WC1E 6DB, United Kingdom. Phone: 44 171 380 9517. Fax: 44 171 388 8514. E-mail: v.gant{at}academic.uclh.nthames.nhs.uk.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |